Product
MCV-A
1 clinical trial
1 indication
Indication
Typhoid FeverClinical trial
A Cluster-randomised Controlled Phase IV Trial Assessing the Impact of a Vi-Polysaccharide Conjugate Vaccine in Preventing Typhoid Infection in Asante Akim, Ghana (TyVEGHA)Status: Recruiting, Estimated PCD: 2024-12-31